Started By
Message

re: Weekly Stock Market Plays/Thoughts - March/April

Posted on 4/20/17 at 5:18 pm to
Posted by BeYou
DFW
Member since Oct 2012
6027 posts
Posted on 4/20/17 at 5:18 pm to
quote:

Who's seen AUPH after hours? Holding $7.50s now with 1.2 million volume “The most exciting aspect of this data is that voclosporin is the first treatment candidate to successfully meet all of its clinical endpoints in a global, prospective LN trial,” said Dr. Samir Parikh, a clinical investigator for the study and Assistant Professor, Clinical Nephrology at the Ohio State University. “Voclosporin, when added to standard of care, achieved the highest complete remission rate of any global, active LN trial, and this was accomplished with extremely low-dose steroid exposure. The possibility of achieving a better clinical response while avoiding the significant side effects associated with prolonged exposure to high dose steroids has the potential to be a game-changer in the management of LN."


I'm holding as well. I wander if this stock is shorted back down though in the coming months without any significant upcoming catalysts.
This post was edited on 4/20/17 at 5:19 pm
Posted by bayoubengals88
LA
Member since Sep 2007
19250 posts
Posted on 4/20/17 at 10:16 pm to
quote:

I wander if this stock is shorted back down though in the coming months without any significant upcoming catalysts.

We just need to gap up to get rid of these current shorts. This stock under $8 is a crying shame.
My faith is in Voclosporin and Glickman. They will prevail over the shorts and manipulation.

Why bet against this drug? Anyone?
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram